Aprea Therapeutics Inc. (APRE)
NASDAQ: APRE
· Real-Time Price · USD
1.60
0.03 (1.91%)
At close: Aug 21, 2025, 9:44 AM
Aprea Therapeutics Revenue
Aprea Therapeutics reported an annual revenue of $1.5M, reflecting a 157.63% growth. For the quarter ending June 30, 2025, Aprea Therapeutics generated $118.11K in revenue.
Revenue (ttm)
1.5M
Revenue Growth
157.63%
Price / Sales Ratio
12.06
Revenue / Employee
187.82K
Employees
8
Market Cap
9.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1.5M | +157.63% |
| Dec 31, 2023 | 583.23K | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |